CN101921798A - Method for preparing gene recombinant human ferritin light chain - Google Patents
Method for preparing gene recombinant human ferritin light chain Download PDFInfo
- Publication number
- CN101921798A CN101921798A CN2009101419740A CN200910141974A CN101921798A CN 101921798 A CN101921798 A CN 101921798A CN 2009101419740 A CN2009101419740 A CN 2009101419740A CN 200910141974 A CN200910141974 A CN 200910141974A CN 101921798 A CN101921798 A CN 101921798A
- Authority
- CN
- China
- Prior art keywords
- ferritin
- light chain
- ferritin light
- recombinant human
- bacterial strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 24
- 101000818390 Homo sapiens Ferritin light chain Proteins 0.000 title claims abstract description 17
- 238000000034 method Methods 0.000 title abstract description 7
- 101001022947 Lithobates catesbeianus Ferritin, lower subunit Proteins 0.000 claims abstract description 27
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 10
- 102100021062 Ferritin light chain Human genes 0.000 claims abstract description 8
- 239000013604 expression vector Substances 0.000 claims abstract description 6
- 108010002084 Apoferritins Proteins 0.000 claims abstract description 5
- 210000000601 blood cell Anatomy 0.000 claims abstract description 5
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims abstract description 4
- 230000001580 bacterial effect Effects 0.000 claims description 15
- 239000013612 plasmid Substances 0.000 claims description 14
- 241000894006 Bacteria Species 0.000 claims description 11
- 230000029087 digestion Effects 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 8
- 238000011156 evaluation Methods 0.000 claims description 6
- 230000000968 intestinal effect Effects 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 239000012634 fragment Substances 0.000 claims description 5
- 102000003960 Ligases Human genes 0.000 claims description 4
- 108090000364 Ligases Proteins 0.000 claims description 4
- 238000003757 reverse transcription PCR Methods 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000012408 PCR amplification Methods 0.000 claims description 2
- 239000013613 expression plasmid Substances 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 238000011084 recovery Methods 0.000 claims description 2
- 230000014509 gene expression Effects 0.000 abstract description 6
- 238000001262 western blot Methods 0.000 abstract description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 3
- 230000006698 induction Effects 0.000 abstract description 3
- 241000588724 Escherichia coli Species 0.000 abstract description 2
- 238000010367 cloning Methods 0.000 abstract 2
- 241000193830 Bacillus <bacterium> Species 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 238000001976 enzyme digestion Methods 0.000 abstract 1
- 230000009465 prokaryotic expression Effects 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
- 108050000784 Ferritin Proteins 0.000 description 18
- 102000008857 Ferritin Human genes 0.000 description 17
- 238000008416 Ferritin Methods 0.000 description 17
- 239000012925 reference material Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 6
- 238000005215 recombination Methods 0.000 description 5
- 230000006798 recombination Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000012827 research and development Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241001494479 Pecora Species 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- 101710099785 Ferritin, heavy subunit Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- XUWPJKDMEZSVTP-LTYMHZPRSA-N kalafungina Chemical compound O=C1C2=C(O)C=CC=C2C(=O)C2=C1[C@@H](C)O[C@H]1[C@@H]2OC(=O)C1 XUWPJKDMEZSVTP-LTYMHZPRSA-N 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a method for preparing a gene recombinant human ferritin light chain. The method comprises the following steps of: amplifying a coding genetic sequence of a ferritin light chain (Ferritin L) in human fresh complete blood cells by PCR, cloning the amplified coding genetic sequence into an expression vector pET-30a by enzyme digestion and connection, transforming E.coli BL21 (DE3), identifying a positive cloning colony, performing induction expression on the Ferritin L by IPTG, and analyzing the antigenicity of the Ferritin L by using Westernblot. The method successfully constructs the prokaryotic expression vector of the FTL, and obtains the pure ferritin light chain by induction expression and purification in colon bacillus. Proved by the Westernblot, the protein has good antigenicity.
Description
Technical field
The invention belongs to technical field of bioengineering, be specifically related to a kind of preparation method of gene recombinant human ferritin light chain.
Background technology
Clinical medical development is more and more higher to accuracy, stability and the susceptibility requirement of assay, and therefore high-quality quality control product, calibration object and reference material are the critical products in the check diagnosis.China is the ferritin product that the application first-generation and the s-generation are organized purifying substantially at present, and its activity, linearity, stability, specificity, susceptibility, shelf time etc. are all widely different owing to the uncertainty in source.Therefore, gene recombination method is used rapidly and is promoted this series products and enters the third generation.Because the ferritin complex structure, the common renaturation of 24 subunit units is extremely difficult, obtain that minimum detectable level, height are tired, the linear gene recombination ferritin standard substance that require is technical very high on a large scale.Therefore, China does not still have gene recombination ferritin standard substance at present.
Because ferritin and inflammatory disorders, hemopathy, hepatopathy, cardiovascular and cerebrovascular diseases, ephrosis and malignant tumour etc. are closely related, in the clinical diagnosis of these diseases, treatment, monitoring, all play important effect.Therefore, study to guaranteeing restriction, stable in properties, the differences between batches gene recombination ferritin standard substance with China's independent intellectual property right little, that use cost is lower that the quality inspection research and development are not originated extremely urgent.Particularly the ferritin detection method of using clinically at present is varied, and the consistence between the whole bag of tricks is difficult to comparison.Domestic expert appeals to make up the ferritin reference material of China oneself already, in the hope of real accuracy and the comparability that solves ferritin mensuration.This research and design a kind of with the method for ferritin light chain (Ferritin L) at expression in escherichia coli, identify through order-checking and Westernblot, confirm to have good antigenicity.Now the result is reported as follows.
Summary of the invention
A technical problem to be solved by this invention provides a kind of preparation method of gene recombinant human ferritin light chain.For production purity ferritin reference material good, stable, that easily store and transport is set up the basis.
For solving the problems of the technologies described above, technical scheme provided by the present invention is:
The invention provides a kind of preparation method of gene recombinant human ferritin light chain, it is characterized in that may further comprise the steps:
(1) adopt the RT-PCR technology from the human blood cell, to obtain the human ferritin light chain gene fragment;
(2) the human ferritin light chain gene fragment subclone that PCR in the step (1) is obtained is to the pGEM-T carrier, transformed competence colibacillus Top10 bacterium, be inoculated in the LB substratum that contains penbritin then, the screening positive clone bacterial strain, extract the plasmid pGEM-T/ferritin L of positive colony bacterial strain, and the evaluation of checking order.
(3) be template with the plasmid pGEM-T/ferritin L in the step (2), carry out pcr amplification, then amplified production is carried out double digestion, simultaneously empty plasmid pET-30a is carried out double digestion, recovery and purifying enzyme are cut product respectively, connect with the T4 ligase enzyme, obtain expression vector, the transformed competence colibacillus intestinal bacteria, be inoculated in the LB substratum that contains kantlex then, the screening positive clone bacterial strain, the expression plasmid pET-30a/ferritin L of extraction positive colony bacterial strain, and the evaluation of checking order.
(4) express the purifying ferritin light chain with the IPTG inducible protein.
Wherein, intestinal bacteria are BL21 or DE3 described in the step (3).
Double digestion is for to carry out double digestion with NdeI and BamHI described in the step (3).
The advantage that the present invention has: at present, China's ferritin national standard product still obtain by purifying.The development of ferritin reference material can solve the disadvantage that the present ferritin reference material of China relies on import for a long time, can set up the reference material of China, and is that the system of tracing to the source of setting up and improve the ferritin detection lays the first stone; For the accuracy, consistence and the reliability that will improve clinical ferritin detection are from now on given security, play important effect for improving China's ferritin observed value comparability, equivalence in the world simultaneously.The present invention is the method for utilization gene recombination, give expression to the light chain of ferritin respectively, and resulting albumen is carried out initial analysis identify, determine the feasibility of ferritin gene reorganization reference material research and development, and provide new thinking for the research and development of clinical other reference material.
Description of drawings
Fig. 1 pET-30a/ferritin L gene amplification product electrophorogram.(1DNA marker; 2pET-30a/ferritin L PCR product)
Fig. 2 pET-30a/ferritin L SDS-PAGE electrophorogram.(1 albumen marker; 2pET-30a/ferritin L expression product)
Embodiment
Adopt embodiment that the present invention is described in further detail below.
Bacterial classification and plasmid
Competence intestinal bacteria Top10 is available from Tiangen company; PGEM-T cloning vector test kit is available from match Parkson, Beijing company; E. coli bl21 (DE3) bacterial strain and expression vector pET-30a are available from Novagen company.
Main agents
Taq archaeal dna polymerase and primer are available from match Parkson, Beijing company; Plasmid extracts test kit, total RNA extraction reagent box and RT-PCR test kit in a small amount available from Beijing Tiangen company; Restriction enzyme is available from NEB company; With toolenzyme such as T4 ligase enzyme available from match Parkson, Beijing company; DNA reclaims test kit available from Tiangen company; Mouse-anti people Ferritin L monoclonal antibody is available from Santa cruz company; The sheep anti-mouse igg of HRP mark is available from the match biology of speeding; Other reagent is homemade or the import analytical pure.
The preparation of embodiment 1 subclone plasmid pGEM-T/ferritin L
Extract total RNA with the Trisol test kit from people's fresh whole blood cell, adopt the RT-PCR technology to obtain the cDNA fragment of human ferritin light chain gene (Ferritin L) from people's fresh whole blood cell, according to the operation of test kit specification sheets, the primer is:
Upstream primer: 5 '-CATATGAGCTCCCAGATTCGTCAG-3 ';
Downstream primer: 5 '-GGATCCTCTTAGTCGTGCTTGAGAG-3 '
Reclaim and purified pcr product after, be connected in 4 ℃ with the pGEM-T carrier and spend the night, transformed competence colibacillus Top10 bacterium inoculates the LB culture dish that contains penbritin, screening positive clone bacterial strain, and the evaluation of checking order.This bacterial strain is the intestinal bacteria that contain Ferritin L encoding sequence plasmid pGEM-T/ferritin L.
The structure of embodiment 2 expression vector pET-30a/ferritin L
With plasmid pGEM-T/FTL is template, carries out double digestion with NdeI and BamHI; Simultaneously with empty plasmid pET-30a NdeI+BamHI double digestion.Reclaim above-mentioned enzyme respectively and cut product, after mixing with suitable proportion, spend the night in 16 ℃ of connections with the T4 ligase enzyme, transformed competence colibacillus BL21 (DE3) bacterium, inoculation contains the LB culture dish of kantlex, screening positive clone bacterial strain.
The plasmid pET-30a/ferritin L that extracts the positive colony bacterial strain evaluation of checking order.Inserting codified among segmental dna sequence dna and the GenBank (among the GenBank number), to contain 175 amino-acid residue ferritin L sequences in full accord, and single open reading frame is correct, the required target protein of codified.As shown in Figure 1.
Embodiment 3Ferritin L induction expression of protein
The engineering bacteria BL21 (DE3) that will contain pET-30a/ferritin L plasmid is inoculated in 5mI and contains in the LB substratum of kantlex (50ml), incubated overnight, press 1: 50 transferred species next day to 1L LB substratum (kalamycin resistance), 37 ℃, about 240r/min rotating and culturing 2h, make A600 reach 0.6-0.8, add inductor IPTG, continue jolting 4h under these conditions to final concentration 1mmol/L.After cultivating end, the centrifugal 10min of 8000g collects bacterial sediment.With PBS washing 3 times, ice-bath ultrasonic cracking thalline, the centrifugal 20min of 12000g, cleer and peaceful precipitation in the separation.
The expressing protein of pET-30a/ferritin L is analyzed through SDS-PAGE, and as shown in Figure 2, visible relative molecular mass is about 20000 expressing protein, and is consistent with the expection size.Handle the back discovery through ultrasonic degradation, target protein is mainly with the formal representation of soluble proteins.
The proteic Westernblot of embodiment 4Ferritin L identifies
Through 10%SDS-PAGE, electricity is transferred on the nitrocellulose filter with Ferritin L, uses mouse-anti people Ferritin L and Ferritin H monoclonal antibody (one is anti-) and HRP-sheep anti-mouse igg (two is anti-) to detect proteic two kinds of antigenicities respectively, develops the color with DAB at last.Ferritin L albumen and two kinds of reaction systems of Ferritin L monoclonal antibody+HRP one sheep anti-mouse igg of expressing, the visible obviously colour developing band at relative molecular mass 20000 places.Show that target protein has good antigenicity.
Claims (3)
1. the preparation method of a gene recombinant human ferritin light chain is characterized in that may further comprise the steps:
(1) adopt the RT-PCR technology from the human blood cell, to obtain the human ferritin light chain gene fragment;
(2) the human ferritin light chain gene fragment subclone that PCR in the step (1) is obtained is to the pGEM-T carrier, transformed competence colibacillus Top10 bacterium, be inoculated in the LB substratum that contains penbritin then, the screening positive clone bacterial strain, extract the plasmid pGEM-T/ferritin L of positive colony bacterial strain, and the evaluation of checking order;
(3) be template with the plasmid pGEM-T/FTL in the step (2), carry out pcr amplification, then amplified production is carried out double digestion, simultaneously empty plasmid pET-30a is carried out double digestion, recovery and purifying enzyme are cut product respectively, connect with the T4 ligase enzyme, obtain expression vector, the transformed competence colibacillus intestinal bacteria, be inoculated in the LB substratum that contains kantlex then, the screening positive clone bacterial strain, the expression plasmid pET-30a/ferritin L of extraction positive colony bacterial strain, and the evaluation of checking order;
(4) express the purifying ferritin light chain with the IPTG inducible protein.
2. the preparation method of gene recombinant human ferritin light chain according to claim 1, it is characterized in that: intestinal bacteria are BL21 or DE3 described in the step (3).
3. the preparation method of gene recombinant human ferritin light chain according to claim 1, it is characterized in that: double digestion is for to carry out double digestion with NdeI and BamHI described in the step (3).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101419740A CN101921798A (en) | 2009-06-12 | 2009-06-12 | Method for preparing gene recombinant human ferritin light chain |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101419740A CN101921798A (en) | 2009-06-12 | 2009-06-12 | Method for preparing gene recombinant human ferritin light chain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101921798A true CN101921798A (en) | 2010-12-22 |
Family
ID=43337013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009101419740A Pending CN101921798A (en) | 2009-06-12 | 2009-06-12 | Method for preparing gene recombinant human ferritin light chain |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101921798A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104357477A (en) * | 2014-11-13 | 2015-02-18 | 武汉金开瑞生物工程有限公司 | Construction and high-density fermentation production method of human ferritin light-chain recombinant Pichia pastoris |
| CN104515847A (en) * | 2013-09-27 | 2015-04-15 | 张曼 | Application of urine ferritin light chains and heavy chains |
| EP2668497A4 (en) * | 2011-01-26 | 2015-09-16 | Univ Pittsburgh | URINARY BIOMARKERS TO PREDICT HEALING AFTER ACUTE RENAL INJURY: PROTEOMIC |
| CN107941791A (en) * | 2017-12-21 | 2018-04-20 | 江苏泽成生物技术有限公司 | A kind of cancer base antigen calibration object method of inspection |
| CN110759986A (en) * | 2019-10-18 | 2020-02-07 | 大连工业大学 | An efficient method for the preparation of reversible self-assembled proteins |
-
2009
- 2009-06-12 CN CN2009101419740A patent/CN101921798A/en active Pending
Non-Patent Citations (5)
| Title |
|---|
| M.R.SUMMERS ET AL: "Iron uptake and ferritin synthesis by peripheral blood leucocytes from normal subjects and patients with iron deficiency and the anaemia of chronic disease", 《BRITISH JOURNAL OF HAEMATOLOGY》 * |
| M.SUMMERS ET AL: "Ferritin Synthesis in Lymphocytes, Polymorphs and Monocytes", 《BRITISH JOURNAL OF HAEMATOLOGY》 * |
| SONIA LEVI ET AL: "Expression and structural and functional properties of human ferritin L-chain from Escherichia coli", 《BIOCHEMISTRY》 * |
| WU XIULI ET AL: "Gene cloning, expression, and characterization of a novel trehalose synthase from Arthrobacter aurescens", 《APPL MICROBIOL BIOTECHNOL》 * |
| 林明等: "从血液中提取总RNA的一种快速高效方法", 《中国生物化学与分子生物学报》 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2668497A4 (en) * | 2011-01-26 | 2015-09-16 | Univ Pittsburgh | URINARY BIOMARKERS TO PREDICT HEALING AFTER ACUTE RENAL INJURY: PROTEOMIC |
| CN104515847A (en) * | 2013-09-27 | 2015-04-15 | 张曼 | Application of urine ferritin light chains and heavy chains |
| CN104515847B (en) * | 2013-09-27 | 2016-08-17 | 张曼 | Urine ferritin light chain and the application of heavy chain |
| CN104357477A (en) * | 2014-11-13 | 2015-02-18 | 武汉金开瑞生物工程有限公司 | Construction and high-density fermentation production method of human ferritin light-chain recombinant Pichia pastoris |
| CN107941791A (en) * | 2017-12-21 | 2018-04-20 | 江苏泽成生物技术有限公司 | A kind of cancer base antigen calibration object method of inspection |
| CN107941791B (en) * | 2017-12-21 | 2020-09-11 | 江苏泽成生物技术有限公司 | Method for detecting cancer blank antigen calibrator |
| CN110759986A (en) * | 2019-10-18 | 2020-02-07 | 大连工业大学 | An efficient method for the preparation of reversible self-assembled proteins |
| CN110759986B (en) * | 2019-10-18 | 2023-01-31 | 大连工业大学 | Efficient preparation method of reversible self-assembled protein |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Baazizi et al. | Peste des petits ruminants (PPR): A neglected tropical disease in Maghreb region of North Africa and its threat to Europe | |
| Chen et al. | Detection and molecular diversity of spike gene of porcine epidemic diarrhea virus in China | |
| Veit et al. | CD8+ T cells responding to the middle east respiratory syndrome coronavirus nucleocapsid protein delivered by vaccinia virus MVA in mice | |
| Zhang et al. | Identification of cold-responsive miRNAs and their target genes in nitrogen-fixing nodules of soybean | |
| CN106947827B (en) | Bighead carp gender specific molecular marker, screening method and application thereof | |
| CN103981263B (en) | The quantitative detecting method of antibiotics resistance gene in soil | |
| CN101921798A (en) | Method for preparing gene recombinant human ferritin light chain | |
| Varsaki et al. | Prevalence and population diversity of Listeria monocytogenes isolated from dairy cattle farms in the Cantabria region of Spain | |
| Taylor et al. | Redondovirus diversity and evolution on global, individual, and molecular scales | |
| Brown-Joseph et al. | Identification and characterization of epizootic hemorrhagic disease virus serotype 6 in cattle co-infected with bluetongue virus in Trinidad, West Indies | |
| Pallaoro et al. | Towards a more realistic in vitro meat: The cross talk between adipose and muscle cells | |
| Kiesler et al. | Prevalence of Linda virus neutralizing antibodies in the Austrian pig population | |
| CN102199201B (en) | Recombinant fungal immunomodulatory protein gene in Ganoderma lucidum, protein coded whereby and application thereof | |
| Liu et al. | Identification and genome characterization of novel feline parvovirus strains isolated in Shanghai, China | |
| Pyz-Łukasik et al. | Genetic diversity and potential virulence of Listeria monocytogenes isolates originating from Polish artisanal cheeses | |
| Solieri et al. | Characterization of cell-envelope proteinases from two Lacticaseibacillus casei strains isolated from Parmigiano Reggiano cheese | |
| Zoghbi-Rodríguez et al. | Phylogenomic and microsynteny analysis provides evidence of genome arrangements of high-affinity nitrate transporter gene families of plants | |
| Yin et al. | Transcriptome analysis of leg muscles and the effects of ALOX5 on proliferation and differentiation of myoblasts in Haiyang Yellow chickens | |
| Yongfeng et al. | Detection of the epidemic of the H3N8 subtype of the equine influenza virus in large-scale donkey farms | |
| CN106701994A (en) | Double PCR (Polymerase chain reaction) primer for simultaneous detection of Klebsiella pneumoniae and Aeromonas caviae and detection method of double PCR primer | |
| Lin et al. | The Flora Compositions of Nitrogen‐Fixing Bacteria and the Differential Expression of nifH Gene in Pennisetum giganteum zx lin Roots | |
| CN109055588A (en) | Specific primer, kit and the PCR detection method of the outstanding Bordetella of a pair of detection uncle | |
| CN109735661A (en) | A kind of universal Porcine epidemic diarrhea virus nested PCR detection method | |
| Kim et al. | Genetic characterization and evolution of porcine deltacoronavirus isolated in the Republic of Korea in 2022 | |
| Olesen et al. | A multi-laboratory comparison of methods for detection and quantification of African swine fever virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20101222 |